P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
OTLK | N/A | N/A | N/A | +10.57% |
OTLK Peer | N/A | N/A | N/A | -29.99% |
Pharmaceuticals: Major Industry | 23.3 | 17.8 | 2.2 | -2.04% |
Health Technology Sector | 51.5 | 23.6 | 1.7 | -33.79% |
S&P 500 Market | 37.2 | 193.8 | 4.0 | +5.16% |
Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
---|---|---|---|---|
Mean Estimate | -$0.06 | -$0.07 | -$0.06 | -$0.07 |
Previous Mean | -$0.06 | -$0.07 | -$0.06 | N/A |
Standard Deviation | 0.02 | 0.01 | 0.01 | N/A |
Low Estimate | -$0.09 | -$0.08 | -$0.08 | -$0.07 |
High Estimate | -$0.04 | -$0.06 | -$0.05 | -$0.07 |